Premium
WS05‐02Sonohysterography in patient treated with SERMs
Author(s) -
Fleischer A. C.
Publication year - 2000
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1046/j.1469-0705.2000.00009-1-31.x
Subject(s) - medicine , adenomyosis , endometrial polyp , selective estrogen receptor modulator , tamoxifen , endometrium , endometrial hyperplasia , urology , radiology , endometriosis , gynecology , cancer , breast cancer
Sonohysterography (SHG) is an established method for detection of polyps, evaluation of submucosal intracavitary fibroids and adhesions as well as abnormal areas of endometrial thickening. This presentation will describe SHG findings for evaluation of punctate cysts both within and adjacent to the endometrium seen in women on selective estrogen receptor modulators (SERMS) Tamoxifen®, and Roloxifene®. The clinical significance of these findings will be discussed. Cystic endometrial atrophy and focal adenomyosis of patients receiving SERMS may the histologic correlate of abnormal sonographic appearances.